China · Delayed Price · Currency is CNY Sage Therapeutics Statistics
Total Valuation
SHA:603170 has a market cap or net worth of CNY 5.05 billion. The enterprise value is 4.82 billion.
| Market Cap | 5.05B |
| Enterprise Value | 4.82B |
Important Dates
The next estimated earnings date is Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | Jun 3, 2025 |
Share Statistics
SHA:603170 has 400.01 million shares outstanding. The number of shares has decreased by -1.09% in one year.
| Current Share Class | 400.01M |
| Shares Outstanding | 400.01M |
| Shares Change (YoY) | -1.09% |
| Shares Change (QoQ) | -2.47% |
| Owned by Insiders (%) | 20.99% |
| Owned by Institutions (%) | 32.92% |
| Float | 253.06M |
Valuation Ratios
The trailing PE ratio is 21.77 and the forward PE ratio is 18.68.
| PE Ratio | 21.77 |
| Forward PE | 18.68 |
| PS Ratio | 1.87 |
| PB Ratio | 3.11 |
| P/TBV Ratio | 3.83 |
| P/FCF Ratio | 33.66 |
| P/OCF Ratio | 17.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.54, with an EV/FCF ratio of 32.16.
| EV / Earnings | 20.91 |
| EV / Sales | 1.79 |
| EV / EBITDA | 12.54 |
| EV / EBIT | 14.70 |
| EV / FCF | 32.16 |
Financial Position
The company has a current ratio of 3.21, with a Debt / Equity ratio of 0.10.
| Current Ratio | 3.21 |
| Quick Ratio | 2.22 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 1.06 |
| Interest Coverage | 61.61 |
Financial Efficiency
Return on equity (ROE) is 16.78% and return on invested capital (ROIC) is 11.85%.
| Return on Equity (ROE) | 16.78% |
| Return on Assets (ROA) | 10.07% |
| Return on Invested Capital (ROIC) | 11.85% |
| Return on Capital Employed (ROCE) | 19.31% |
| Revenue Per Employee | 2.06M |
| Profits Per Employee | 176,369 |
| Employee Count | 1,308 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 6.84 |
Taxes
In the past 12 months, SHA:603170 has paid 89.73 million in taxes.
| Income Tax | 89.73M |
| Effective Tax Rate | 25.11% |
Stock Price Statistics
The stock price has increased by +10.97% in the last 52 weeks. The beta is 0.59, so SHA:603170's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +10.97% |
| 50-Day Moving Average | 12.76 |
| 200-Day Moving Average | 13.73 |
| Relative Strength Index (RSI) | 54.59 |
| Average Volume (20 Days) | 2,859,762 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603170 had revenue of CNY 2.70 billion and earned 230.69 million in profits. Earnings per share was 0.58.
| Revenue | 2.70B |
| Gross Profit | 882.84M |
| Operating Income | 328.15M |
| Pretax Income | 357.28M |
| Net Income | 230.69M |
| EBITDA | 374.07M |
| EBIT | 328.15M |
| Earnings Per Share (EPS) | 0.58 |
Balance Sheet
The company has 574.10 million in cash and 159.62 million in debt, giving a net cash position of 414.47 million or 1.04 per share.
| Cash & Cash Equivalents | 574.10M |
| Total Debt | 159.62M |
| Net Cash | 414.47M |
| Net Cash Per Share | 1.04 |
| Equity (Book Value) | 1.62B |
| Book Value Per Share | 3.58 |
| Working Capital | 891.27M |
Cash Flow
In the last 12 months, operating cash flow was 289.90 million and capital expenditures -139.93 million, giving a free cash flow of 149.97 million.
| Operating Cash Flow | 289.90M |
| Capital Expenditures | -139.93M |
| Free Cash Flow | 149.97M |
| FCF Per Share | 0.37 |
Margins
Gross margin is 32.75%, with operating and profit margins of 12.17% and 8.56%.
| Gross Margin | 32.75% |
| Operating Margin | 12.17% |
| Pretax Margin | 13.25% |
| Profit Margin | 8.56% |
| EBITDA Margin | 13.87% |
| EBIT Margin | 12.17% |
| FCF Margin | 5.56% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 3.16%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 3.16% |
| Dividend Growth (YoY) | 6.67% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 91.03% |
| Buyback Yield | 1.09% |
| Shareholder Yield | 4.25% |
| Earnings Yield | 4.57% |
| FCF Yield | 2.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603170 has an Altman Z-Score of 9.54 and a Piotroski F-Score of 5.
| Altman Z-Score | 9.54 |
| Piotroski F-Score | 5 |